Invesco Biotechnology & Genome ETF (NY:PBE)
Price and Volume
Detailed Quote| Volume | 542 |
| Open | 82.03 |
| Bid (Size) | 82.15 (300) |
| Ask (Size) | 82.35 (100) |
| Prev. Close | 82.11 |
| Today's Range | 82.03 - 82.22 |
| 52wk Range | 54.52 - 83.59 |
| Shares Outstanding | 34,500 |
| Dividend Yield | 0.57% |
Top News
More NewsPerformance
More News
Read More
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗
February 19, 2024
US Judge Weighs Nationwide Ban On Abortion Pills ↗
March 16, 2023
7 Best Biotech Stocks to Buy in July 2022 ↗
July 08, 2022
Biotech ETFs That Outperformed Last Week ↗
December 20, 2021
A Comprehensive Guide To Genomic ETFs ↗
July 11, 2021
5 Top ETFs With Exposure To Biogen ↗
June 07, 2021
5 Top ETFs With Exposure To Biogen ↗
June 07, 2021
Frequently Asked Questions
Is Invesco Biotechnology & Genome ETF publicly traded?
Yes, Invesco Biotechnology & Genome ETF is publicly traded.
What exchange does Invesco Biotechnology & Genome ETF trade on?
Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Biotechnology & Genome ETF?
The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange
What is the current price of Invesco Biotechnology & Genome ETF?
The current price of Invesco Biotechnology & Genome ETF is 82.22
When was Invesco Biotechnology & Genome ETF last traded?
The last trade of Invesco Biotechnology & Genome ETF was at 12/04/25 10:23 AM ET
What is the market capitalization of Invesco Biotechnology & Genome ETF?
The market capitalization of Invesco Biotechnology & Genome ETF is 2.84M
How many shares of Invesco Biotechnology & Genome ETF are outstanding?
Invesco Biotechnology & Genome ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
